Neoplasms

All Conditions

Skin and Connective Tissue Diseases

Infections

Symptoms and General Pathology

Rare Diseases

Carcinoma

Carcinoma, Basal Cell

Skin Neoplasms

Carcinoma, Merkel Cell

Carcinoma, Skin Appendage

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Neoplasms, Basal Cell

Communicable Diseases

Polyomavirus Infections

Virus Diseases

DNA Virus Infections

Tumor Virus Infections

Carcinoma, Neuroendocrine

Neuroendocrine Tumors

Neuroectodermal Tumors

Neuroectodermal Tumors, Primitive

Neoplasms, Germ Cell and Embryonal

Adenocarcinoma

Neoplasms, Nerve Tissue

Merkel Cell Carcinoma

Neuroendocrine Tumor

Neuroepithelioma

Dermatologic Agents

All Drugs and Chemicals

Laurent MORTIER, MD,PhD

Benoit Minart

Catherine Lok, MD

Ludovic Martin, MD

Julie De Quatrebarbes, MD

François Aubin, MD

Eve Maubec, MD

Philippe Saiag, MD

Laurent Misery, MD

Laurence VERNEUIL, MD, PhD

Michel d'Incan, MD

sophie DALAC, md

Marie-Therese Leccia, MD

Nathalie BENETON-BENHARD, md

Christophe Bedane, MD

Patrick Combemasle, MD

Jean Jacques Grob, MD

Bernard Guillot, MD

Florence Granel-Brocard, MD

Brigitte DRENO, MD, PhD

Jean Philippe Lacour, MD

Guido Bens, MD

Vincent Descamps, MD

Selim Aractingi, MD

Celeste Lebbe, MD

Marie BEYLOT-BARRY, MD, PhD

luc THOMAS, md,phd

Nadège Cordel, MD

Gerard Guillet, MD

Florent Grange, MD

Alain Dupuy

Pascal JOLY, MD, PhD

Dan Lipsker, MD

Nicolas MEYER, MD, PhD

Laurent Machet, MD

Caroline ROBERT, MD, PhD

Merkel cell carcinoma, advanced basal cell carcinoma requiring systemic treatment, and cutaneous adnexal carcinomas are 3 types of rare skin cancers for which much remains unknown in terms of natural behavior, prognosis, treatment and outcomes.

CARADERM is a French prospective national cohort enrolling patients with either one of these 3 tumor types, whose objectives are :

* to provide epidemiological, clinical and socio-economic characteristics of patients
* to identify new clinical or epidemiological prognostic factors for these rare cancers
* to evaluate the impact of various treatments on outcomes

CARADERM is a French national multidisciplinary project which will prospectively enroll from 37 French centers any patient presenting with Merkel cell carcinoma, advanced basal cell carcinoma requiring systemic treatment or cutaneous adnexal carcinoma.

A structured and centralized database of clinical monitoring of patients will be established. Information captured will include clinical constitutional factors, factors linked to primary carcinoma, factors linked to lymph node involvement, "American Joint Committee on Cancer" (AJCC) stage at inclusion, recurrence patterns, therapeutic interventions (medical, surgical, radiotherapy and palliative strategies) with evaluation of response, date of death, date of latest news.

French National Database of Rare Dermatological Cancers

French National Database of Rare Dermatological Cancers: Merkel Cell Carcinoma, Inoperable or Metastatic Basal Cell Carcinoma, Cutaneous Adnexal Carcinomas

University Hospital, Lille

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
French National Database of Rare Dermatological Cancers	NCT03210935	Adnexal Tumor o... Merkel Cell Car... Advanced Basal ...		-	University Hospital, Lille
French National Database of Rare Dermatological Cancers	NCT03210935	Adnexal Tumor o... Merkel Cell Car... Advanced Basal ...		-	University Hospital, Lille

Spots Global Cancer Trial Database for advanced basal cell carcinoma requiring systemic treatment